Product Information

LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1509 per EA under NDC 00378728753. Its NADAC has been published 629 times since Aug 6, 2014.

FDA first approved this application on Oct 9, 2013. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVONOR-ETH ESTRAD 0.1-0.02 MG

Levonorgestrel and Ethinyl Estradiol
$0.1509per EA

NDC

00378728753

Classification

Generic

Dosage Form

KIT

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200245

FDA Approved

10/9/2013

TE Code

AB1

On Market Since

6/26/2014

Price Statistics

The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 629 times since Aug 6, 2014, and over the history we have for it it has declined 66.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1509 per EA
All-time high$0.5937 (Apr 13, 2016)
All-time low$0.1212 (Jul 17, 2024)
52-week high$0.1741
52-week low$0.1509
Median price$0.2446
Average price$0.2937
Largest weekly change+35.3% (Jun 19, 2024)
Weeks tracked629
Tracking sinceAug 6, 2014

Price History

1W

-1.1%

1M

-1.1%

3M

-3.0%

6M

-7.5%

1Y

-4.7%

3Y

-17.9%

5Y

-29.0%

All

-66.4%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?

The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.1509 per EA (NDC 00378728753), effective Aug 19, 2026.

How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?

Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has declined 66.4%. It has been tracked across 629 weekly CMS publications since Aug 6, 2014.

What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?

Since Aug 6, 2014, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.5937 (Apr 13, 2016), with a median of $0.2446 per EA.

Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1128 per EA — about 25% below LEVONOR-ETH ESTRAD 0.1-0.02 MG.

Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?

LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 00378728753) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.